Investing Profile

Kanad Das

InvestorVC

Investment Director at Boehringer Ingelheim Venture Fund

boehringer-ingelheim-venture....San Francisco, California
Photo of Kanad Das, Investor at Boehringer Ingelheim Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$3.3M - $17.0M
$8.5M
3
CompanyStageDateRound SizeTotal Raised
OncoMyx Therapeutics
Series BDec 2021$50M
Series AJun 2019$25M
$75M
Actym Therapeutics, Inc.
Series AApr 2020$34M
$34M